Investigational Drug Shows Promise in Myotonic Dystrophy Type 1

(MedPage Today) -- Investigational zeleciment basivarsen (z-basivarsen) led to functional improvement in patients with myotonic dystrophy type 1 (DM1), data from the phase I/II ACHIEVE trial suggested. The analysis evaluated whether a larger group...